Rocket Companies Inc. (NYSE: RKT): Keefe Bruyette lifted its Underperform rating to Market Perform with an $11.50 target. The consensus target is just $8.58. Monday’s $11.58 close was up almost 4% for the day on the upgrade.
Sage Therapeutics Inc. (NASDAQ: SAGE): Stifel downgraded the stock to Hold from Buy. The analyst also slashed its $60 target price to $22. The consensus target is $61.28 for now. The last trade on Monday was for $16.75 a share. That was a 53% one-day retreat, after the FDA rejected a major depressive disorder treatment on which Sage partnered with Biogen.
Southwest Airlines Co. (NYSE: LUV): Redburn’s downgrade was from Neutral to Sell with a $27 target price. The consensus target is $37.61 for now. The shares closed on Monday at $32.97.
Tanger Factory Outlet Centers Inc. (NYSE: SKT): Compass Point upgraded the stock to Buy from Neutral, and its $21 target price increased to $26. The consensus target is $20.42. The stock closed over 3% higher on Monday at $25.01.
United Airlines Holdings Inc. (NYSE: UAL): Redburn upgraded the stock to Buy from Neutral and has an $80 target price. The consensus target is $71.29 for now. The shares were last seen trading at $53.68, up over 2% on Monday.
Vistagen Therapeutics Inc. (NASDAQ: VTGN): Maxim upgraded the shares from Hold to Buy with a $30 target price. The consensus target is $6 for now. The shares closed on Monday at $13.05, a one-day gain of 675%, as the company produced positive data on its nasal spray.
Wayfair Inc. (NYSE: W): UBS raised its Neutral rating to Buy and its $72 target price to $110. The consensus target is much lower at $77.14. The stock ended Monday trading at $83.26, and the company posted outstanding quarterly results last week.
XPO Inc. (NYSE: XPO): Oppenheimer reiterated an Outperform rating. Its $82 target price compares with a consensus target of $60.77 and Monday’s close at $72.28.
Seven outstanding stocks make sense for growth and income investors looking to add energy, as they are rated Buy, come with large and dependable dividends and have solid upside to the posted price targets.
Monday’s top analyst upgrades and downgrades included Amazon.com, Amgen, Apple, BioCryst Pharmaceuticals, Block, Coinbase Global, Datadog, Fortinet, Gilead Sciences, Intercontinental Exchange, Moderna, Monster Beverage, Nvidia, PayPal and Petrobras.
Originally published at 24/7 Wall St.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
